Investors Press Releases Year All2024202320222021 Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting Apr 23, 2024 Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control Apr 09, 2024 Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update Mar 28, 2024 Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024 Mar 06, 2024 Omega Therapeutics Announces Research Collaboration with Novo Nordisk to Develop a Novel Therapeutic for Obesity Management Jan 04, 2024 Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference Jan 02, 2024
Year All2024202320222021 Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting Apr 23, 2024 Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control Apr 09, 2024 Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update Mar 28, 2024 Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024 Mar 06, 2024 Omega Therapeutics Announces Research Collaboration with Novo Nordisk to Develop a Novel Therapeutic for Obesity Management Jan 04, 2024 Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference Jan 02, 2024
